Response to: Second-line treatment of non-small-cell lung cancer with wild-type EGFR status. What is the best approach?
Division of Hematology/Oncology, McGill University, Montreal, Quebec.
Ma
M
Kim Anh
Peter Brojde Lung Cancer Centre, Jewish General Hospital, Montreal, Quebec.
Goulnar
G
Kasymjanova
Peter Brojde Lung Cancer Centre, Jewish General Hospital, Montreal, Quebec.
Victor
V
Cohen
Peter Brojde Lung Cancer Centre, Jewish General Hospital, Montreal, Quebec.
Jason
J
Agulnik